# Coxsackie A2, A7, B1, B3, B4, B5 Nosodes

NDC: 43742-2571
Generic name: Coxsackie A2, A7, B1, B3, B4, B5 Nosodes
Labeler / Manufacturer: Deseret Biologicals
Product type: DRUG FOR FURTHER PROCESSING
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: LIQUID
Routes: —
Marketing started: 20261029



## Active ingredients

- HUMAN COXSACKIEVIRUS A2: 1 [hp_M]/mL
- HUMAN COXSACKIEVIRUS A7: 1 [hp_M]/mL
- HUMAN COXSACKIEVIRUS B1: 1 [hp_M]/mL
- HUMAN COXSACKIEVIRUS B3: 1 [hp_M]/mL
- HUMAN COXSACKIEVIRUS B4: 1 [hp_M]/mL
- HUMAN COXSACKIEVIRUS B5: 1 [hp_M]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43742-2571"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43742-2571